| David P Taormina, MD | |
|
6300 E Lake Blvd Ste 201, Vancleave, MS 39565-6771 | |
| (228) 230-2663 | |
| (228) 546-3257 |
| Full Name | David P Taormina |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 6300 E Lake Blvd Ste 201, Vancleave, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851702807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 32495 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bienville Orthopaedic Specialists, Llc | 0547155178 | 47 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Harvard School of Public Health researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company"), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company recently passed the Chinese National Institute for the Control of Pharmaceutical and Biological Products ("ICPBP") examination for two of its new products: its Diagnostic Kit for Human Prostate Specific Antigen (Colloidal Gold) and its Determination Kit for Luteinizing Hormone (Colloidal Gold).
› Verified 5 days ago
| Entity Name | Bienville Orthopaedic Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689605834 PECOS PAC ID: 0547155178 Enrollment ID: O20040220000834 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Harvard School of Public Health researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company"), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company recently passed the Chinese National Institute for the Control of Pharmaceutical and Biological Products ("ICPBP") examination for two of its new products: its Diagnostic Kit for Human Prostate Specific Antigen (Colloidal Gold) and its Determination Kit for Luteinizing Hormone (Colloidal Gold).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David P Taormina, MD 6300 E Lake Blvd Ste 301, Vancleave, MS 39565-6771 Ph: (228) 230-2663 | David P Taormina, MD 6300 E Lake Blvd Ste 201, Vancleave, MS 39565-6771 Ph: (228) 230-2663 |
News Archive
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
Harvard School of Public Health researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites within infected blood cells, potentially containing the disease.
Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company"), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company recently passed the Chinese National Institute for the Control of Pharmaceutical and Biological Products ("ICPBP") examination for two of its new products: its Diagnostic Kit for Human Prostate Specific Antigen (Colloidal Gold) and its Determination Kit for Luteinizing Hormone (Colloidal Gold).
› Verified 5 days ago
Matthew Wesley Lewis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-206-2263 Fax: 228-206-1192 | |
Charles Joseph Winters, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd Ste 201, Vancleave, MS 39565 Phone: 228-230-2663 Fax: 228-546-3257 | |
Dr. Daniel Allen Wittersheim, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-230-2663 Fax: 228-206-1192 | |
Dr. John Kirk Drake, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-230-2663 Fax: 228-206-1192 | |
Thomas Jordan Lucak, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd Ste 201, Vancleave, MS 39565 Phone: 228-230-2663 Fax: 228-546-3257 | |
Dr. Christopher Burks, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 301, Vancleave, MS 39565 Phone: 228-230-2663 Fax: 228-206-1192 |